REGN $374.26 +2.48 (0.67%)
Regeneron Pharmaceuticals Inc
Regeneron Stock Charts
The 5 year and 1 year stock charts are below.
50 Day Moving Average
The 50 Day Moving Average is at $355.70 which is 5.22% below the stock price of $374.26.
200 Day Moving Average
The 200 Day Moving Average is at 348.24 which is 7.47% below the stock price of $374.26.
Because both the 50 DMA and 200 DMA are below the current stock price, this can be considered a bullish technical indicator.
Notice that the 200 Day Moving Average is crossing upward through the 50 Day Moving Average.
This is called a "Golden Cross" which is an extremely bullish technical analysis chart pattern.
REGN Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $374.26.
The Year To Date (YTD) return is -2.18%.
52 Week Low
The 52 Week Low stock price is $281.89 set on Wed, May 9, 2018 which is 103 days ago.
The current price per share is 32.77% above the 52 week low.
52 Week High
The 52 Week High stock price is $505.49 set on Fri, Sep 1, 2017 which is 353 days ago.
The current price per share is -25.96% below the 52 week high.
All Time High
The All Time High stock price is $605.93 set on Tue, Aug 4, 2015 which is 1,112 days ago.
The current price per share is -38.23% below the all time high.
Below is the EPS, P/E Ratio and Earnings Date.
The Earnings Per Share (EPS) is $13.77.
The Price To Earnings (P/E) Ratio is 28.42.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Regeneron Pharmaceuticals Inc was Thu, May 3, 2018.
Since this earnings release 109 days ago, the stock price is up by +26.38%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Thu, Aug 2, 2018, which was 18 days ago.
Since this earnings date, the stock price is up by +0.87%.
Below is important Dividend information.
REGN currently does not pay a dividend.
You may like this list of best dividend stocks of 2018.
Below are other Biotech & Pharma stocks as Regeneron.
REGN Company Profile
Learn more about Regeneron.
Regeneron Pharmaceuticals Inc is a Health Care stock that trades on the NASDAQ and has a market capitalization of $40.69 Billion.
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.
Spend a few minutes browsing the Regeneron Pharmaceuticals Inc, web site at http://www.regeneron.com.